Liquid biopsy company Angle said the University of Southern California had published peer-reviewed results of work undertaken in metastatic breast cancer highlighting advantages of its technology. The university had also shown that potential therapeutic targets were found in the the company''s liquid biopsy that were missed in the tissue biopsy of a single metastatic site. At 2:23pm: (LON:AGL) Angle PLC share price was 0p at 56p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.